It has been shown that astrocytes from HD patients become physiologically and morphologically activated when exposed to mutant huntingtin, as determined by increased GFAP staining and morphological changes—specifically, thicker processes and a larger somata (Faideau et al., 2010). This evidence concerns the gene HTT and Huntington disease.